How much funding has Vivos raised?

Vivos has disclosed $725K raised across 1 of its 2 known rounds.

Where is Vivos headquartered?

Vivos is headquartered in Richland, US.

Vivos

OTC: RDGL

Richland, US · Delaware corporation

Find your way into Vivos

Paths you didn't know you had: your email and LinkedIn already hold routes to the Vivos team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Vivos Inc. is a medical device company developing Precision Radionuclide Therapy (PRnT), a treatment that delivers targeted radiation directly into cancerous tumors via an injectable radionuclide device. Its technology is applied to cancer treatment in humans (RadioGel) and animals (IsoPet), operating in the precision oncology and radionuclide therapy space.

Biotech Healthtech Medical Devices

Founders & leadership

Michael K. KorenkoExecutive

Carlton CadwellNamed on SEC filing

Leonard JolliffNamed on SEC filing

Reported raises · per SEC filings

Form D private placements

$725K disclosed across 1 of 2 rounds · 2015–2018

▶$725KraisedOct 2018 · 15 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

Carlton CadwellDirector
Michael K. KorenkoExecutive Officer, Director
Leonard JolliffExecutive Officer

Offering amount: $2M
Amount sold: $725K
Finders' fees: $50K
First sale: Oct 2018
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Frequently asked questions

What does Vivos do?: Vivos Inc. is a medical device company developing Precision Radionuclide Therapy (PRnT), a treatment that delivers targeted radiation directly into cancerous tumors via an injectable radionuclide device. Its technology is applied to cancer treatment in humans (RadioGel) and animals (IsoPet), operating in the precision oncology and radionuclide therapy space.
How much funding has Vivos raised?: Vivos has disclosed $725K raised across 1 of its 2 known rounds.
Where is Vivos headquartered?: Vivos is headquartered in Richland, US.